187 related articles for article (PubMed ID: 23200547)
1. Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
Wingard JR
Best Pract Res Clin Haematol; 2012 Dec; 25(4):487-91. PubMed ID: 23200547
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
[TBL] [Abstract][Full Text] [Related]
3. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid.
Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K
Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957
[TBL] [Abstract][Full Text] [Related]
4. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
Einsele H; Loeffler J
Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.
Norkin M; Wingard JR
J Natl Compr Canc Netw; 2013 Aug; 11(8):941-9. PubMed ID: 23946173
[TBL] [Abstract][Full Text] [Related]
6. Invasive fungal infections: biomarkers and molecular approaches to diagnosis.
Schuetz AN
Clin Lab Med; 2013 Sep; 33(3):505-25. PubMed ID: 23931836
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
[TBL] [Abstract][Full Text] [Related]
8. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
Schwarzinger M; Sagaon-Teyssier L; Cabaret O; Bretagne S; Cordonnier C;
PLoS One; 2013; 8(6):e65776. PubMed ID: 23799048
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.
Oz Y; Kiraz N
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):289-98. PubMed ID: 21417868
[TBL] [Abstract][Full Text] [Related]
10. Comparison of PCR, (1-->3)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis.
Hashimoto A; Yamakami Y; Kamberi P; Yamagata E; Karashima R; Nagaoka H; Nasu M
J Clin Lab Anal; 1998; 12(5):257-62. PubMed ID: 9773954
[TBL] [Abstract][Full Text] [Related]
11. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
12. Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.
Miyazaki T; Kohno S; Mitsutake K; Maesaki S; Tanaka K; Ishikawa N; Hara K
J Clin Microbiol; 1995 Dec; 33(12):3115-8. PubMed ID: 8586684
[TBL] [Abstract][Full Text] [Related]
13. Two non-invasive diagnostic tools for invasive aspergilosis: (1-3)-beta-D-glucan and the galactomannan assay.
Kelaher A
Clin Lab Sci; 2006; 19(4):222-4. PubMed ID: 17181127
[TBL] [Abstract][Full Text] [Related]
14. [Aspergillus galactomannan detection in allogenic hematopoietic cell transplantation].
Rovira Tarrats M; Puig de la Bellacasa J
Rev Iberoam Micol; 2003 Sep; 20(3):111-5. PubMed ID: 15456367
[TBL] [Abstract][Full Text] [Related]
15. New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients.
Wingard JR
Best Pract Res Clin Haematol; 2007 Mar; 20(1):99-107. PubMed ID: 17336260
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
17. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of fungal infection: new technologies for the mycology laboratory.
Alexander BD
Transpl Infect Dis; 2002; 4 Suppl 3():32-7. PubMed ID: 12486790
[TBL] [Abstract][Full Text] [Related]
19. (1 --> 3)-beta-D-glucan--a new marker for the early serodiagnosis of deep-seated fungal infections in humans.
Kedzierska A
Pol J Microbiol; 2007; 56(1):3-9. PubMed ID: 17419183
[TBL] [Abstract][Full Text] [Related]
20. Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
Mokaddas E; Burhamah MHA; Ahmad S; Khan ZU
J Med Microbiol; 2010 Dec; 59(Pt 12):1519-1523. PubMed ID: 20724511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
